• 1
    LAM RW. Chronic schizophrenia and idiopathic Parkinson’s disease. Can. J. Psychiatry 1993; 38: 7577.
  • 2
    Höflich G, Burghof KW, Kasper S, Moller HJ. Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease. Nervenarzt 1994; 65: 202205.
  • 3
    Schwarz J, Scherer J, Trenkwalder C, Mozley PD, Tatsch K. Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: Need for levodopa therapy? Psychiatry Res. 1998; 83: 2328.
  • 4
    Friedman JH, Fernandez HH. Autopsy follow-up of a patient with schizophrenia and presumed idiopathic Parkinson’s disease. Clin. Neuropharmacol. 2001; 24: 120121.
  • 5
    Plotkin M, Amthauer H, Klaffke S et al. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients. J. Neural Transm. 2005; 112: 13551361.
  • 6
    Becker G, Berg D. Neuroimaging in basal ganglia disorders: Perspectives for transcranial ultrasound. Mov. Disord. 2001; 16: 2332.